BRAIN announces €60m round of financing to expand its buy-and-build strategy
20-Nov-2012
- Germany
The largest ever round of financing in the area of white biotechnology is led by BRAIN shareholders MP Beteiligungs-GmbH (Family Office PUTSCH) based in Kaiserslautern, Germany, and MIG Fonds, one of the largest institutional investors in the area of biotechnology, and involves several other investors.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.